For over 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. As the global market and technology leader in magnetic resonance and preclinical imaging, Bruker offers a wide range of applications for molecular characterization in chemistry and life sciences as well as solutions for materials and preclinical research. The Bruker BioSpin business group includes NMR, EPR, compact and Time-Domain (TD) NMR, preclinical MRI, optical imaging, microCT, and PET/SPECT/CT.